2022
DOI: 10.1016/j.molliq.2022.120398
|View full text |Cite
|
Sign up to set email alerts
|

Effects of p-sulfonatocalixarene and p-sulfonatocalixarene/sulfobetaine surfactant complex on the activities of bromelain and polyphenol oxidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…In this case, the smallest calix [4]arene represents the ideal scaffold to develop inhibitors, due to its rigidity that strongly reduces the entropic penalty typical of every binding process. Calixarene derivatives are efficient inhibitors of alkaline phosphatase, [34][35][36] ion channels, [37] histone deacetylase, [38] galectin-1, [39,40] glutathione-S-transferase, [41,42] tyrosine phosphatase, [43][44][45][46] HIV-1 integrase, [47,48] HIV protease, [49] protein disulfide isomerase, [50] AXL tyrosine kinase receptor, [51] HIV-1 nucleocapsid protein, [52] α-mannosidase, [53] bromelain and polyphenol oxidase, [54] and carbonic anhydrase. [55] Over the last twenty years, a substantial amount of work was carried out to study the interaction of calixarene derivatives with biomolecules, in particular to identify their interactions with druggable proteins.…”
Section: Introductionmentioning
confidence: 99%
“…In this case, the smallest calix [4]arene represents the ideal scaffold to develop inhibitors, due to its rigidity that strongly reduces the entropic penalty typical of every binding process. Calixarene derivatives are efficient inhibitors of alkaline phosphatase, [34][35][36] ion channels, [37] histone deacetylase, [38] galectin-1, [39,40] glutathione-S-transferase, [41,42] tyrosine phosphatase, [43][44][45][46] HIV-1 integrase, [47,48] HIV protease, [49] protein disulfide isomerase, [50] AXL tyrosine kinase receptor, [51] HIV-1 nucleocapsid protein, [52] α-mannosidase, [53] bromelain and polyphenol oxidase, [54] and carbonic anhydrase. [55] Over the last twenty years, a substantial amount of work was carried out to study the interaction of calixarene derivatives with biomolecules, in particular to identify their interactions with druggable proteins.…”
Section: Introductionmentioning
confidence: 99%
“…Calixarenes, due to their tunable size up to giant calixarenes 14 and to their large possibilities of functionalization, 15,16 are associated with many applications in biological fields, as chemotherapy delivery carriers, 17,18 protein inhibitors 19,20 and surface binders-recognizers. 21,22 The specific interaction with overall positively-charged proteins, like cytochrome-C, 6,23 lysozyme 24 and small antifungal proteins (PAF), 25,26 makes calixarenes ideal ligand host partners 27 in encapsulating positivelycharged residues such as lysines and arginines, 28 as their binding is governed by electrostatic interactions.…”
Section: Introductionmentioning
confidence: 99%
“…1A. It consists in unbiased, diffusion MD simulations with many independent replica (20), followed by ''Bound-state'' and free energy MD simulations, based on the Attach-Pull-Release (APR) [33][34][35] method, to: (i) assign de novo plausible competitive binding sites, independently from the crystallographic ones, (ii) estimate the free energy of binding to be compared to ITC measurements and (iii) characterize the dynamics of binding and possible structural consequences on competitive salt bridges.…”
Section: Introductionmentioning
confidence: 99%
“…Calixarenes, due to their tunable size up to giant calixarenes 16 and to their large possibilities of functionalization [17][18][19][20][21] , are associated with many applications in biological fields, as chemotherapy delivery carriers [22][23][24][25][26][27] , protein inhibitors 28,29 and surface binders-recognizers 15,[30][31][32] .…”
Section: Introductionmentioning
confidence: 99%